SCHEMBL5871631

SCHEMBL5871631

O=[N+]([O-])c1ccc2c(c1)N(C1CCNCC1)CC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.46
PNMT P11086 1/20 0.46
NOS1 P29475 3/20 0.45
NOS3 P29474 2/20 0.45
NOS2 P35228 2/20 0.45
HTR2C P28335 5/20 0.45
HTR2B P41595 4/20 0.45
ROCK1 Q13464 1/20 0.44
DPP4 P27487 1/20 0.42
ADRB1 P08588 1/20 0.41
SIRT6 Q8N6T7 1/20 0.41
HTT P42858 1/20 0.40
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
SLC6A4 P31645 1/20 0.39
CYP2C19 P33261 1/20 0.39
THPO P40225 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL429286 0.85 HTR1A (0.48) ROCK1DPP4SIRT6HTTALDH1A1
SCHEMBL31378746 0.80 ROCK1 (0.44) ROCK1DPP4SIRT6HTTALDH1A1
SCHEMBL12459066 0.78 ALDH1A1 (0.53) DPP4ALDH1A1CYP1A2DRD2
SCHEMBL7804878 0.77 ACHE (0.59) DRD2
SCHEMBL5871326 0.76 HTR2C (0.66) NOS1NOS3NOS2HTR2CHTR2B
SCHEMBL5871363 0.76 HTR2C (0.50) ADRA2APNMTNOS1NOS3NOS2
SCHEMBL4995439 0.76 HTR2C (0.63) ADRA2ANOS1NOS3NOS2HTR2C
Hydrochloric Acid SCHEMBL16279347 0.75 HTR2C (0.64) NOS1NOS3NOS2HTR2CHTR2B
SCHEMBL3357679 0.75 DPP4 (0.50) NOS1NOS3NOS2DPP4SIRT6
Fluorobenzene SCHEMBL27559462 0.74 HTR1A (0.42) HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7071201-B2 Serotonin antagonism; muscle relaxant for myotonia; such as 1-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)-7-methoxy-1,2,3,4 -tetrahydroquinoline EISAI CO., LTD. (JP) 2006-07-04 US disclosed
CN-1204121-C 1,4-substituted cyclic amine derivatives EISAI CO LTD (JP) 2005-06-01 CN disclosed
EP-0976732-B1 1,4-SUBSTITUTED CYCLIC AMINE DERIVATIVES EISAI CO LTD (JP) 2004-11-24 EP disclosed
US-6579881-B2 Indoles EISAI CO., LTD. (JP) 2003-06-17 US disclosed
US-6448243-B1 SEROTONIN ANTAGONIST FOR TREATING, AMELIORATING AND PREVENTING SPASTIC PARALYSIS OR CENTRAL MUSCLE RELAXANTS FOR AMELIORATING MYOTONIA EISAI CO., LTD. (JP) 2002-09-10 US disclosed
US-20020086999-A1 Certain quinoline derivatives EISAI CO., LTD. 2002-07-04 US disclosed
US-20020019531-A1 Indoles EISAI CO., LTD. 2002-02-14 US disclosed
CN-1253547-A 1,4-substituted cyclic amine derivatives EISAI CO LTD (JP) 2000-05-17 CN disclosed
EP-0976732-A1 1,4-SUBSTITUTED CYCLIC AMINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-02-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019531-A1 Indoles INMT, MUSK, MB ADRA2A 301/4885PNMT 21/4885NOS1 241/4885
US-20020086999-A1 Certain quinoline derivatives CHRM1, CHRNA5, CHRNA4 ADRA2A 203/4885PNMT 56/4885NOS1 258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.